# Innate Pharma SA: Form 6-K, filed Mar 6, 2024

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2024-03-06
- Accepted by EDGAR: Mar 6, 2024, 06:00 ET
- Period: 2024-03-06
- Accession: 0001598599-24-000007
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000159859924000007/a6kincorporated-iphx240603.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000159859924000007/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000159859924000007/a6kincorporated-iphx240603.htm

Filed Mar 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001598599-24-000007. Last ingested by Listed: Nov 5, 2026, 11:30 ET. No prices; not investment advice.